Financial Terms
In exchange for all of Cyclis’ outstanding shares on a fully diluted basis
- $5 million cash, 4.6 million shares of ArQule’s stock
Assumed liabilities in $5-$6 million range
Deal expected to close August 2003
- subject to customary closing conditions and Cyclis shareholder approval